JP3178311U - tablet - Google Patents
tablet Download PDFInfo
- Publication number
- JP3178311U JP3178311U JP2012002878U JP2012002878U JP3178311U JP 3178311 U JP3178311 U JP 3178311U JP 2012002878 U JP2012002878 U JP 2012002878U JP 2012002878 U JP2012002878 U JP 2012002878U JP 3178311 U JP3178311 U JP 3178311U
- Authority
- JP
- Japan
- Prior art keywords
- tablet
- drug
- abbreviation
- name
- marking
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Landscapes
- Medical Preparation Storing Or Oral Administration Devices (AREA)
Abstract
【課題】薬局或いは医療機関における錠剤の調剤後の監査や持参薬の管理において、また、服用者が服用時に、薬剤を容易に識別し得る錠剤を提供する。
【解決手段】錠剤の表面に薬剤名又はその略名１をマーキングしてなる錠剤を構成する。より好ましい錠剤は、錠剤の表面中央に錠剤含量２に対応する数字をマーキングし、その上下に薬剤名又はその略名１及び会社名３又はその略称・略号をそれぞれマーキングしてなる錠剤であって、錠剤の両面にマーキングしたものである。
【選択図】図１Disclosed is a tablet capable of easily identifying a drug in a pharmacy or a medical institution after auditing the administration of a tablet or managing a brought-in drug, and when a user takes the drug.
A tablet is formed by marking a drug name or its abbreviation 1 on the surface of a tablet. More preferable tablets are tablets formed by marking a number corresponding to the tablet content 2 at the center of the surface of the tablet and marking the drug name or its abbreviation 1 and the company name 3 or its abbreviation and abbreviation above and below it. , Marked on both sides of the tablet.
[Selection] Figure 1
Description
本考案は、薬局或いは医療機関における錠剤の調剤後の監査や持参薬の管理において、また、服用者が服用時に、薬剤を容易に識別し得るように薬剤情報がその表面に表示された錠剤に関するものである。 The present invention relates to a tablet on which the drug information is displayed on the surface so that the drug can be easily identified at the time of taking an audit or administration of a medicine taken after dispensing the tablet in a pharmacy or medical institution. Is.
現在、薬局或いは医療機関等において服用時期毎に薬剤を同一袋内に充填し
て投与する所謂一包化調剤が行われている。しかしながら、一包化調剤の際に
錠剤の包装は解かれるために、従来の錠剤つまり薬剤情報が記号で刻印された
錠剤は薬剤の識別が困難であり、誤調剤の原因の一つとされてきた。
Currently, so-called single-packed preparations in which drugs are filled and administered in the same bag every time they are taken are performed at pharmacies or medical institutions. However, since the packaging of the tablets is released at the time of single-packed dispensing, conventional tablets, that is, tablets in which drug information is engraved with symbols are difficult to identify drugs and have been regarded as one of the causes of incorrect dispensing. .
また、薬剤投与後、特に数種の薬剤を服用している服用者は服用時毎に正し
い薬剤を服用しなければならないが、上述のような従来の薬剤は薬剤の識別が
困難であるため誤服用の危険性が否めない。
In addition, after administration of a drug, those who are taking several types of drugs must take the correct drug every time they are taken. However, conventional drugs such as those mentioned above are difficult to identify because they are difficult to identify. There is no denying the risk of taking it.
さらに、服用者が他の医療機関へ罹る際に服薬情報の管理が必要であるが、
従来の薬剤は薬剤の識別が困難であるため薬剤管理に薬剤師は時間を要し、監
査業務等の時間を圧迫するために調剤過誤の原因にもなりかねない。
Furthermore, it is necessary to manage medication information when the user suffers from other medical institutions.
Since it is difficult to identify a conventional drug, the pharmacist needs time to manage the drug, and it may cause a dispensing error because the time for the auditing work is pressed.
本考案の課題は、薬局或いは医療機関における錠剤の調剤後の監査や持参薬の管理において、また、服用者が服用時に、薬剤を容易に識別し得る錠剤を提供することにある。 The subject of this invention is providing the tablet which can identify a chemical | medical agent easily in the audit | inspection after administration of the tablet in a pharmacy or a medical institution, management of a medicine to bring, and a user at the time of taking.
本考案は、薬剤の視認性を向上させるために、薬剤名や他の薬剤情報をマー
キングしてなることを特徴とする錠剤を特徴とする。
The present invention is characterized by a tablet characterized by marking a drug name or other drug information in order to improve drug visibility.
また、薬剤名他の薬剤情報が両面にマーキングされた錠剤を特徴とする。 In addition, the tablet is characterized in that drug information such as drug name is marked on both sides.
本考案は、薬剤名他の薬剤情報をマーキングされた錠剤で、これにより調剤過誤や誤服用による健康被害を防止することが可能となる。 The present invention is a tablet on which drug information such as a drug name is marked, and this makes it possible to prevent health damage due to dispensing errors or misuse.
薬剤の処方の際あるいは患者が薬剤を服用する際に、薬剤名や服用量等を容易に確認できる錠剤を得るという目的を、その表面に最小限必要な当該情報をマーキングすることにより実現した。 The purpose of obtaining a tablet with which the drug name, dosage, etc. can be easily confirmed at the time of drug prescription or when a patient takes the drug is realized by marking the surface with the minimum necessary information.
図１は、前期特許文献１に記載の方法により、錠剤の表面中央に錠剤含量に対応する数字をマーキングし、その上下に薬剤名又はその略名及び会社名又はその略称・略号をそれぞれマーキングしたもので、その平面図を示したものである。 In FIG. 1, a number corresponding to the tablet content is marked in the center of the surface of the tablet by the method described in Patent Document 1, and the drug name or its abbreviation and the company name or its abbreviation / abbreviation are respectively marked above and below it. The plan view is shown.
本考案の錠剤は、薬剤名、含量、メーカー等を容易に確認することができるので、薬剤の誤服用等の医療過誤を防ぐことができ、極めて有用である。 Since the tablet of the present invention can easily confirm the drug name, content, manufacturer, etc., it can prevent medical errors such as drug misuse and is extremely useful.
１ 薬剤名の略名
２ 薬剤含有量に対応する数字
３ 会社名の略称
1 Abbreviated name of drug name 2 Number corresponding to drug content 3 Abbreviated name of company name
Claims (5)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012002878U JP3178311U (en) | 2012-05-16 | 2012-05-16 | tablet |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2012002878U JP3178311U (en) | 2012-05-16 | 2012-05-16 | tablet |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP3178311U true JP3178311U (en) | 2012-09-13 |
Family
ID=48005057
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2012002878U Expired - Fee Related JP3178311U (en) | 2012-05-16 | 2012-05-16 | tablet |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP3178311U (en) |
-
2012
- 2012-05-16 JP JP2012002878U patent/JP3178311U/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Al-Worafi et al. | Drug safety in China | |
| Mendonça et al. | Analysis and detection of dental prescribing errors at primary health care units in Brazil | |
| de las Mercedes Martínez Sánchez | Medication errors in a Spanish community pharmacy: nature, frequency and potential causes | |
| Gunningberg et al. | Medication administration accuracy: using clinical observation and review of patient records to assess safety and guide performance improvement | |
| García et al. | Current evidence in the stability of medicines in dose administration aids: implications for patient safety | |
| Parthasarathi et al. | Evaluation of medication errors in a tertiary care hospital of a low-to middle-income country | |
| Oldenmenger et al. | Analgesic adherence measurement in cancer patients: comparison between electronic monitoring and diary | |
| Arulogun et al. | Prescription errors prevalent in four units of a University Teaching Hospital in Nigeria | |
| Sarzynski et al. | Medication Reconciliation in an Outpatient Geriatrics Clinic: Does Accuracy Improve If Patients' Brown Bag'Their Medications for Appointments? | |
| JP3178311U (en) | tablet | |
| Carrington | Safe use of oral cytotoxic medicines | |
| Biswas et al. | Prevalence and nature of handwritten outpatients prescription errors in Bangladesh | |
| Hamza et al. | Rates and types of prescribing errors and related interventions in oncology | |
| Hin et al. | Oncology pharmacist’s role and impact on the multidisciplinary patient-centre practice of oncology clinic in public hospitals | |
| Alakhali et al. | Medication errors at the outpatient pharmacy in Aseer Region Kingdom of Saudi Arabia | |
| Patton | Increased use of oral chemotherapy drugs spurs increased attention to patient compliance | |
| Grissinger et al. | Reducing harm in patients using insulin | |
| Villamañán et al. | The assisted electronic prescription in patients hospitalised in a chest diseases ward | |
| Grissinger | Tablet splitting—only if you “half” to | |
| Lombardi et al. | Drug Information Update: Considerations with Prescribing and Distributing Oral Chemotherapy. | |
| Edgar et al. | Common medication errors in long-term care settings | |
| JP5419787B2 (en) | Medicine dose management system | |
| Hung et al. | Copyright 2021 International Pharmaceutical Federation (FIP) International Pharmaceutical Federation (FIP) Andries Bickerweg 5 2517 JP The Hague The Netherlands | |
| Adsley | Multi-compartment compliance aids for addressing poor adherence | |
| Man Hin et al. | Oncology pharmacist's role and impact on the multidisciplinary patient-centre practice of oncology clinic in public hospitals in Hong Kong |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Written amendment |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20120705 |
|
| R150 | Certificate of patent or registration of utility model |
Ref document number: 3178311 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20150822 Year of fee payment: 3 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
| LAPS | Cancellation because of no payment of annual fees |